Trastuzumab deruxtecan

Item number	Size	Delivery time	Price
TGM-T36646-1mg	1 mg	7 - 10 business days*	727.00€
TGM-T36646-5mg	5 mg	7 - 10 business days*	1,482.00€
TGM-T36646-10mg	10 mg	7 - 10 business days*	1,961.00€
TGM-T36646-25mg	25 mg	7 - 10 business days*	2,984.00€
TGM-T36646-50mg	50 mg	7 - 10 business days*	3,935.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Trastuzumab deruxtecan (T-DXd) is an antibody-activated molecule coupling (ADC) with... more

Close menu

Product information "Trastuzumab deruxtecan"

Description: Trastuzumab deruxtecan (T-DXd) is an antibody-activated molecule coupling (ADC) with anticancer and antitumour activity.Trastuzumab deruxtecan has been shown to have an ameliorative effect in HER2-positive breast and gastric cancers. Target: Others, Antibody-Drug Conjugates (ADCs). References: Kumagai K, et al. Interstitial pneumonitis related to trastuzumab deruxtecan, a human epidermal growth factor receptor 2-targeting Ab-drug conjugate, in monkeys. Cancer Sci. 2020 Dec,111(12):4636-4645.

Keywords:	DS-8201a, VRN-101099, DS 8201, T-DXd
Supplier:	TargetMol
Supplier-Nr:	T36646

Properties

Application:	Targets receptor tyrosine-protein kinase erbB-2 [EC:2.7.10.1] (ERBB2, HER2, CD340)
Conjugate:	No
MW:	45.42 kD

Database Information

CAS :	1826843-81-5\| Matching products
KEGG ID :	K03163 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Trastuzumab deruxtecan"

Write a review